Pericardial Effusion in Adults: a systematic review of epidemiology, etiologies, diagnosis, and management – ​​updated 2025

Authors

DOI:

https://doi.org/10.5281/zenodo.17795010

Keywords:

pericardial effusion, cardiac tamponade, pericardiocentesis, pericardium, echocardiography

Abstract

Introduction: Pericardial effusion (PE) is defined as an abnormal accumulation of fluid in the pericardial space and encompasses a wide spectrum of etiologies, ranging from benign conditions to life-threatening causes such as cardiac tamponade. Advances in imaging, image-guided interventions and understanding of the underlying pathophysiology justify an updated synthesis of the literature. Objective: To systematically review contemporary evidence on the epidemiology, etiologies, imaging-based diagnosis and therapeutic management of pericardial effusion in adults, focusing on studies published between 2000 and 2025. Methods: A systematic search was conducted in PubMed/MEDLINE, Embase, Cochrane Library and Google Scholar. Eligible studies included cohort and observational studies, clinical series with ≥20 patients, systematic reviews and guidelines. Pre-clinical, pediatric-only, very small series and purely narrative reviews were excluded. Two independent reviewers screened and selected the studies according to PRISMA principles. Extracted data included epidemiology, causes, diagnostic methods, echocardiographic parameters, management strategies (pericardiocentesis, surgery, adjuvant therapies), prognosis and recurrence. Results: A total of 3,274 records were identified, of which 82 met inclusion criteria. The most frequent etiologies were idiopathic/viral (20–30%), neoplastic (10–25%), post-operative (15–20%), uremic (5–15%), tuberculosis (in endemic regions: up to 70% of severe cases), autoimmune diseases (5–10%) and hypothyroidism (up to 5%). Transthoracic echocardiography remains the main diagnostic tool, while tomography and cardiac magnetic resonance are useful in complex or loculated effusions. Management is driven by effusion volume, rate of accumulation and hemodynamic impact. Image-guided pericardiocentesis shows a success rate of 92–98% with low procedure-related mortality (<1%), whereas malignant effusions present higher recurrence rates (up to 40%). Surgical pericardial window is associated with lower recurrence at the cost of greater invasiveness. Conclusion: Pericardial effusion is a multifactorial condition requiring rapid and structured evaluation. Echocardiography is the cornerstone of diagnosis, and image-guided pericardiocentesis remains the first-line intervention in symptomatic or hemodynamically unstable effusions. Ongoing advances in imaging, biomarkers and minimally invasive therapies continue to improve outcomes.

References

Adler, Y.; Charron, P.; Imazio, M. et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal, v. 36, n. 42, p. 2921–2964, 2015.

Imazio, M.; Gaita, F.; LeWinter, M. Evaluation and treatment of pericarditis: a systematic review. JAMA, v. 314, n. 14, p. 1498–1506, 2015.

Sagristà-Sauleda, J.; Merce, J.; Permanyer-Miralda, G.; Soler-Soler, J. Clinical clues to the causes of large pericardial effusions. American Journal of Medicine, v. 109, n. 2, p. 95–101, 2000.

Maisch, B.; Seferović, P. M.; Ristić, A. D. et al. Guidelines on the diagnosis and management of pericardial diseases.European Heart Journal, v. 25, n. 7, p. 587–610, 2004.

Vakamudi, S.; Ho, N.; Cremer, P. Pericardial Effusions: Causes, Diagnosis, and Management. Progress in Cardiovascular Diseases, v. 59, n. 4, p. 380–388, 2017.

Rafique, A. M.; Patel, N.; Biner, S. et al. Frequency of recurrence of pericardial effusion requiring pericardiocentesis.American Journal of Cardiology, v. 108, n. 12, p. 1820–1824, 2011.

Tsang, T. S. M.; Freeman, W. K.; Barnes, M. E. et al. Clinical and echocardiographic characteristics of significant pericardial effusion in adults. American Journal of Cardiology, v. 89, n. 4, p. 442–446, 2002.

Reuter, H.; Reuter, D.; van der Merwe, L. et al. Tuberculous pericardial effusion: Predictors for poor outcomes in the modern era. South African Medical Journal, v. 113, n. 3, p. 154–160, 2023.

Ben-Horin, S.; Bank, I.; Guetta, V.; Livneh, A. Large pericardial effusion: A prospective study of the etiologic profile and clinical course. Clinical Cardiology, v. 29, n. 6, p. 313–317, 2006.

Shapiro, L. M. Pericardial diseases. Heart, v. 75, n. 5, p. 498–504, 1996.

Kumar, P.; Chhabra, L.; Spodick, D. H. Pericardial diseases in oncology. Cardio-Oncology, v. 5, n. 1, p. 1–12, 2019.

Corey, G. R.; Campbell, P. T.; Van Trigt, P. et al. Etiology of large pericardial effusions. American Journal of Medicine, v. 95, n. 2, p. 209–213, 1993.

Imazio, M.; Lazaros, G.; Picordini, A. et al. Colchicine for Prevention of Postpericardiotomy Syndrome and Postoperative Atrial Fibrillation. Circulation, v. 144, n. 6, p. 441–450, 2021.

Colombo, A.; Olson, H. G.; Dunn, J. K.; Gobel, F. L. Etiology and prognostic implications of a large pericardial effusion in 140 consecutive patients. American Journal of Cardiology, v. 64, n. 14, p. 939–942, 1989.

Corey, W. et al. Safety and efficacy of echo-guided pericardiocentesis. Journal of the American Society of Echocardiography, v. 9, n. 2, p. 214–218, 1996.

Maisch, B.; Ristić, A. D. Modern management of pericardial effusion. Current Opinion in Cardiology, v. 27, n. 3, p. 308–316, 2012.

Adler, Y.; Charron, P.; Imazio, M. Pericardial diseases in 2022: review of updates. European Heart Journal, v. 43, p. 1230–1241, 2022.

Published

2025-12-02

Issue

Section

Articles

How to Cite

MELO, Matheus Pinho Nakashima de; DANTAS NETO, Jailton de Lucena. Pericardial Effusion in Adults: a systematic review of epidemiology, etiologies, diagnosis, and management – ​​updated 2025. Journal of Social Issues and Health Sciences (JSIHS), [S. l.], v. 2, n. 6, 2025. DOI: 10.5281/zenodo.17795010. Disponível em: https://ojs.thesiseditora.com.br/index.php/jsihs/article/view/501.. Acesso em: 5 dec. 2025.